Royal jelly is a milky secretion made by young honeybees, sold as a dietary supplement and traditional tonic for vitality and healthy aging. The clearest human benefit is relief of menopausal symptoms, with reasonable support for lowering markers of oxidative damage. Blood-sugar and cholesterol effects are small and inconsistent, and the longevity claim has never been tested in people. It can trigger severe, occasionally fatal allergic reactions and asthma attacks. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Fasting blood glucose | 75–85 mg/dL | Tracks any metabolic effect and hypoglycemia risk with diabetes drugs |
| HbA1c | <5.4% | Reflects average blood sugar over ~3 months |
| LDL cholesterol | <100 mg/dL (lower if high cardiovascular risk) | Detects possible lipid changes |
| Triglycerides | <90 mg/dL | Sensitive to metabolic shifts |
| hs-CRP | <1.0 mg/L | Gauges the anti-inflammatory effect |
| Blood pressure | <120/80 mmHg | Detects additive lowering with blood-pressure drugs |
| Liver enzymes (ALT and AST) | ALT ~<25 U/L | Screens general safety |
| Serum IgE / allergy history | Not a numeric range | Flags allergy risk before starting |
Cadence: Baseline before starting; recheck metabolic and inflammatory markers at about 8–12 weeks, then every 6–12 months if continued. Blood pressure or blood sugar more often in the first 4–8 weeks for anyone on blood-pressure or diabetes medication.